July 2015

New Product - Adenuric

Adenuric (febuxostat) is a potent, nonpurine, selective inhibitor of xanthine oxidase (XO) that prevents the normal oxidation of purines to uric acid. Adenuric is indicated in the treatment of chronic symptomatic hyperuricaemia in conditions where urate deposition has already occurred (gouty arthritis and/or tophus formation) in adults with gout. Adenuric is available as an 80 mg tablet in packs of 28’s.

This list is a summary of only some of the changes that have occurred over the last month. Before prescribing, always refer to the full product information.

Copyright © MIMS Australia Pty Ltd. All rights reserved.

MIMS Australia
Level 2, 1 Chandos Street
St Leonards NSW 2065
Phone: 1800 800 629
info@mims.com.au
www.mims.com.au